-
|
Reuters –
3:19 AM ET 06/30/2022
Uno sguardo alla giornata da Julien Ponthus. Gli investitori in cerca di segni della recessione hanno appreso poco che già non sapessero dai principali banchieri centrali del mondo riuniti alla conferenza annuale della Bce in Portogallo.
|
-
|
|
Reuters –
2:52 AM ET 06/30/2022
A look at the day ahead in markets from Julien Ponthus. Investors on recession watch learnt little they didn't already know from the world's top central bankers gathered at the European Central Bank's annual conference in Portugal.
|
-
|
|
Reuters –
2:47 AM ET 06/30/2022
A look at the day ahead in markets from Julien Ponthus. Investors on recession watch learnt little they didn't already know from the world's top central bankers gathered at the European Central Bank's annual conference in Portugal.
|
-
|
|
Reuters –
06/29/2022
A look at the day ahead in markets from Julien Ponthus. Much of the market rebound from the lows hit on June 17 was credited to data being arguably bad enough to encourage central banks to go easy on their aggressive policy tightening plans yet good enough to suggest a recession could be avoided.
|
-
|
|
Reuters –
06/29/2022
A look at the day ahead in markets from Julien Ponthus. Much of the market rebound from the lows hit on June 17 was credited to data being arguably bad enough to encourage central banks to go easy on their aggressive policy tightening plans yet good enough to suggest a recession could be avoided.
|
RBGPF currently has no events.
Events
 More News & Events
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads;…
View more
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
View less
Environmental, Social & Governance Summary (ESG)
ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities.
Learn more
Full Time Employees: --
Executives
www.reckitt.com
Turner House, 103-105 Bath Road
Slough, SL1 3UH
United Kingdom
1-44 17 5321 7800
|
|
The Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion.
Learn More....
Log in
to view the Equity Summary Score for RBGPF
Log in
to view all Analyst Opinions for RBGPF
VARIOUS THIRD PARTIES
This generated report* compiles independent, third-party information highlighting key fundamental and technical data, analyst opinions, stock price movement, earnings data, and industry comparisons. Available only to Fidelity customers.
S&P Global
This generated report* has historical data on financials with interactive charts, technical indicators, and five-year peer comparison trend charts.
RBGPF Industry Comparison: | RBGPF | Industry Average | Percentile
in Industry |
|---|
| Market Capitalization | -- | -- | -- |
|---|
Total Return (1 Year Annualized)
AS OF | -- | -- | -- |
|---|
| Beta | -- | -- | -- |
|---|
EPS (TTM)
AS OF  | -- | -- | -- |
|---|
| Current Consensus EPS Estimate | -- | -- | -- |
|---|
EPS Growth
(TTM vs. Prior TTM) | -- | -- | -- |
|---|
P/E (TTM)
AS OF | -- | -- | -- |
|---|
Dividend Yield (Annualized)
AS OF 06/29/2022 | -- | 2.51% | -- |
|---|
Total Revenue (TTM)
AS OF | -- | -- | -- |
|---|
Revenue Growth
(TTM vs Prior TTM) | -- | -- | -- |
|---|
| Shares Outstanding | -- | -- | -- |
|---|
| Institutional Ownership | -- | -- | -- |
|---|
|
Print
Log In Required
Line of Credit Log In Required